glp 1 drugs microdosing GLP-1 Why we launched Noom's Microdose

The pathophysiology of this condition is incompletely understood but thought to be related to hypoperfusion of the optic nerve head leading to edema and infarction of optic nerve fibers (87, 88)

Although these findings offer reassurance regarding the safety of these drugs, further validation is essential

AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease: A report of the American heart association/American college of cardiology joint committee on clinical practice guidelines

Annals of medicine

Investor Relations & Media Contact Email: [email protected] Wolfgang Probst Co-Founder, CFO & Director Phone: +49 151 25284192 Hugh Rogers Co-Founder, CEO & Director Phone: +1 604-250-6162 Web: www.bionxt.com LinkedIn: Instagram: Cautionary Statement Regarding "Forward-Looking" Information This news release contains "forward-looking information" and "forward-looking statements" within the meaning of applicable securities laws (collectively, "forward-looking statements")